<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30410495</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.</ArticleTitle><Pagination><StartPage>2479</StartPage><MedlinePgn>2479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.02479</ELocationID><Abstract><AbstractText>Tripartite motif-containing 21 (TRIM21) is a regulator of tissue inflammation and pro-inflammatory cytokine production, and has been implicated in negative regulation of IRF3-dependent type I interferon signaling. However, the antiviral activity of TRIM21 varies among diverse viruses and its role on regulation of type I interferon remains inconsistent in different microbial infections. Here, we investigate the potential role for TRIM21 in controlling Coxsackievirus B3 (CVB3) replication and susceptible organ pathology. We found that CVB3 infection up-regulated the expression of TRIM21 in hearts of mice and cardiomyocytes at early phase of infection. Knock-down of TRIM21 resulted in increased viral replication, while overexpression led to increased phosphorylation and dimerization of IRF3, increased IFN-&#x3b2; transcription and reduced viral replication <i>in vitro</i>. We demonstrate that TRIM21 promotes the activation of IRF3 in CVB3-infected cells via interacting with MAVS and catalyzing the K27-linked polyubiquitination of MAVS, thereby enhancing type I interferon signaling. The RING domain of ubiquitin ligase activity and PRY-SPRY domain of TRIM21 are critical for its anti-viral effect. <i>In vivo</i> overexpression of TRIM21 significantly protected mice against viral myocarditis by suppressing CVB3 replication and reducing cardiac inflammatory cytokine production. While TRIM21 deficient mice exhibited a decreased IFN-&#x3b2; production, an increased cardiac and pancreatic CVB3 replication, and aggravated pancreatic injury as well as myocarditis during acute infection. Thus, our results demonstrate TRIM21 as a positive regulator of IFN-&#x3b2; signaling by targeting MAVS during CVB3 infection and suggest it as a potent host defense against CVB3 infection and viral-induced injury in hearts and pancreas.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yahui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512612">IPS-1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494233">Irf3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012261">Ribonucleoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C035401">SS-A antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012261" MajorTopicYN="N">Ribonucleoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IFN-&#x3b2;</Keyword><Keyword MajorTopicYN="N">IRF3</Keyword><Keyword MajorTopicYN="N">TRIM21</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3 (CVB3)</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30410495</ArticleId><ArticleId IdType="pmc">PMC6209670</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.02479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Ann Rev Pathol. (2008) 3:127&#x2013;55. 10.1146/annurev.pathmechdis.3.121806.151534</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. (2006) 19:133&#x2013;46. 10.1089/vim.2006.19.133</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.133</ArticleId><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaaloul I, Riabi S, Harrath R, Hunter T, Hamda KB, Ghzala AB, et al. . Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Molecul Med Rep. (2014) 10:2811&#x2013;8. 10.3892/mmr.2014.2578</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2578</ArticleId><ArticleId IdType="pmc">PMC4227425</ArticleId><ArticleId IdType="pubmed">25241846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT, Jr. Myocarditis. Lancet (2012) 379:738&#x2013;47. 10.1016/s0140-6736(11)60648-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(11)60648-x</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung PK, Yuan J, Zhang HM, Chau D, Yanagawa B, Suarez A, et al. . Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism. J Med Virol. (2005) 77:414&#x2013;24. 10.1002/jmv.20470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20470</ArticleId><ArticleId IdType="pubmed">16173012</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Kalimo H, Bergelson J, Stanway G, Hyypia T. Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J General Virol. (2005) 86(Pt 7):1897&#x2013;907. 10.1099/vir.0.80603-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80603-0</ArticleId><ArticleId IdType="pubmed">15958668</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res. (1998) 51:35&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">9891585</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, et al. . Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. (1993) 68:159&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">7689428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation (1999) 99:1091&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">10051305</ArticleId></ArticleIdList></Reference><Reference><Citation>Short KM, Cox TC. Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J Biol Chem. (2006) 281:8970&#x2013;80. 10.1074/jbc.M512755200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M512755200</ArticleId><ArticleId IdType="pubmed">16434393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. (2017) 42:297&#x2013;311. 10.1016/j.tibs.2017.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.01.002</ArticleId><ArticleId IdType="pubmed">28118948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano S, Miyajima N, Fukuda S, Hatakeyama S. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res. (2008) 68:5572&#x2013;80. 10.1158/0008-5472.can-07-6231</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.can-07-6231</ArticleId><ArticleId IdType="pubmed">18632609</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M, Manzoor S, Saalim M, Resham S, Ashraf J, Javed A, et al. . HIV-1 and hijacking of the host immune system: the current scenario. APMIS (2016) 124:817&#x2013;31. 10.1111/apm.12579</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12579</ArticleId><ArticleId IdType="pubmed">27539675</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicenzi E, Poli G. The interferon-stimulated gene TRIM22: a double-edged sword in HIV-1 infection. Cytokine Growth Factor Rev. (2018) 40:10&#x2013;7. 10.1016/j.cytogfr.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2018.02.001</ArticleId><ArticleId IdType="pubmed">29650252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim KH, Park ES, Kim DH, Cho KC, Kim KP, Park YK, et al. . Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of TRIM22. Gut (2018) 67:166&#x2013;78. 10.1136/gutjnl-2016-312742</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312742</ArticleId><ArticleId IdType="pubmed">28341749</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, et al. . TRIM22 inhibits influenza a virus infection by targeting the viral nucleoprotein for degradation. J Virol. (2013) 87:4523&#x2013;33. 10.1128/jvi.02548-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02548-12</ArticleId><ArticleId IdType="pmc">PMC3624352</ArticleId><ArticleId IdType="pubmed">23408607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Shi HX, Liu XY, Shan YF, Wei B, Chen S, et al. . TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol. (2009) 182:3782&#x2013;92. 10.4049/jimmunol.0803126</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0803126</ArticleId><ArticleId IdType="pubmed">19265157</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs R, Ni Gabhann J, Ben Larbi N, Breen EP, Fitzgerald KA, Jefferies CA. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol. (2008) 181:1780&#x2013;6. 10.4049/jimmunol.181.3.1780</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.3.1780</ArticleId><ArticleId IdType="pmc">PMC2824853</ArticleId><ArticleId IdType="pubmed">18641315</ArticleId></ArticleIdList></Reference><Reference><Citation>Manocha GD, Mishra R, Sharma N, Kumawat KL, Basu A, Singh SK. Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells. J Neuroinflamm. (2014) 11:24. 10.1186/1742-2094-11-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-24</ArticleId><ArticleId IdType="pmc">PMC3922089</ArticleId><ArticleId IdType="pubmed">24485101</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Li H, Guo M, Wang J, Xu Y, Zou X, et al. . TRIM21 Promotes innate immune response to RNA viral infection through Lys27-Linked Polyubiquitination of MAVS. J Virol. (2018) 92. 10.1128/jvi.00321-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00321-18</ArticleId><ArticleId IdType="pmc">PMC6026736</ArticleId><ArticleId IdType="pubmed">29743353</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, et al. . Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol. (2014) 88:3369&#x2013;78. 10.1128/jvi.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Yan K, Wei L, Yang J, Lu C, Xiong F, et al. . Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Antiviral Res. (2015) 123:50&#x2013;61. 10.1016/j.antiviral.2015.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.001</ArticleId><ArticleId IdType="pubmed">26343012</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana FJ, et al. . Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med. (2009) 206:1661&#x2013;71. 10.1084/jem.20090585</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20090585</ArticleId><ArticleId IdType="pmc">PMC2722164</ArticleId><ArticleId IdType="pubmed">19635858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P, et al. . Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol. (2007) 179:26&#x2013;30. 10.4049/jimmunol.179.1.26</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.1.26</ArticleId><ArticleId IdType="pubmed">17579016</ArticleId></ArticleIdList></Reference><Reference><Citation>Oke V, Vassilaki I, Espinosa A, Strandberg L, Kuchroo VK, Nyberg F, et al. . High Ro52 expression in spontaneous and UV-induced cutaneous inflammation. J Invest Dermatol. (2009) 129:2000&#x2013;10. 10.1038/jid.2008.453</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2008.453</ArticleId><ArticleId IdType="pubmed">19194477</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauner S, Zhou W, Backlin C, Green TM, Folkersen L, Ivanchenko M, et al. . Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease. J Internal Med. (2015) 278:323&#x2013;32. 10.1111/joim.12375</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12375</ArticleId><ArticleId IdType="pubmed">25880119</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang MX, Hong X, Liao BB, Shi SZ, Lai XF, Zheng HY, et al. . Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation. Sci Rep. (2017) 7:42781. 10.1038/srep42781</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42781</ArticleId><ArticleId IdType="pmc">PMC5314404</ArticleId><ArticleId IdType="pubmed">28211536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. (2009) 21:317&#x2013;37. 10.1093/intimm/dxp017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxp017</ArticleId><ArticleId IdType="pmc">PMC2721684</ArticleId><ArticleId IdType="pubmed">19246554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, He C, Wang L, Ge B. Post-translational regulation of antiviral innate signaling. Eur J Immunol. (2017) 47:1414&#x2013;26. 10.1002/eji.201746959</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201746959</ArticleId><ArticleId IdType="pmc">PMC7163624</ArticleId><ArticleId IdType="pubmed">28744851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu YJ. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol. (2013) 14:172&#x2013;8. 10.1038/ni.2492</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2492</ArticleId><ArticleId IdType="pmc">PMC3645272</ArticleId><ArticleId IdType="pubmed">23222971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozato K, Shin DM, Chang TH, Morse HC, III. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. (2008) 8:849&#x2013;60. 10.1038/nri2413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2413</ArticleId><ArticleId IdType="pmc">PMC3433745</ArticleId><ArticleId IdType="pubmed">18836477</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Dinh PX, Pattnaik AK. Trim21 regulates Nmi-IFI35 complex-mediated inhibition of innate antiviral response. Virology (2015) 485:383&#x2013;92. 10.1016/j.virol.2015.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.08.013</ArticleId><ArticleId IdType="pubmed">26342464</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, et al. . Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation (2014) 130:1589&#x2013;600. 10.1161/circulationaha.114.009847</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.114.009847</ArticleId><ArticleId IdType="pubmed">25165091</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkinson RE, Tam JC, Vaysburd MJ, James LC. Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. J Virol. (2013) 87:7309&#x2013;13. 10.1128/jvi.00647-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00647-13</ArticleId><ArticleId IdType="pmc">PMC3700317</ArticleId><ArticleId IdType="pubmed">23596308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakebrandt N, Lentes S, Neumann H, James LC, Neumann-Staubitz P. Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica. Pathog Dis. (2014) 72:131&#x2013;7. 10.1111/2049-632x.12192</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2049-632x.12192</ArticleId><ArticleId IdType="pubmed">24920099</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottermann M, James LC. Intracellular antiviral immunity. Adv Virus Res. (2018) 100:309&#x2013;54. 10.1016/bs.aivir.2018.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC7172442</ArticleId><ArticleId IdType="pubmed">29551141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>